These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 15318714
1. [Optimal conditions for producing immunomodulating effect of epithalamine as component of neoadjuvant chemotherapy using autoplasma and autoblood in patients with locally advanced breast cancer]. Zlamnik EIu, Vladimirova LIu, Zakora GI. Vopr Onkol; 2004; 50(3):357-60. PubMed ID: 15318714 [Abstract] [Full Text] [Related]
2. [Effect of new chemotherapeutic methods on the biologic tissue environment and on the immune status of patients with breast cancer]. Sidorenko IuS, Zlatnik EIu, Vladimirova LIu, Zakora GI. Vopr Onkol; 2002; 48(2):202-5. PubMed ID: 12227069 [Abstract] [Full Text] [Related]
5. Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer. Ma CD, Chen CM, Chen XS, Liu GY, Di GH, Wu J, Lu JS, Yang WT, Chen JY, Shao ZM, Shen ZZ, Shen KW. Anticancer Res; 2008; 28(5B):3093-7. PubMed ID: 19031963 [Abstract] [Full Text] [Related]
7. [Improvement of the indicators of cellular immunity under the effect of polypeptide epiphyseal extract (epithalamine)]. Dil'man VM. Vopr Onkol; 1977; 23(6):7-9. PubMed ID: 303411 [Abstract] [Full Text] [Related]
10. Neoadjuvant chemotherapy in stage III breast cancer. Alassas M, Chu Q, Burton G, Ampil F, Mizell J, Li BD. Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927 [Abstract] [Full Text] [Related]
11. Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy. Yonemori K, Katsumata N, Kaneko M, Uno H, Matsumoto K, Kouno T, Shimizu C, Ando M, Takeuchi M, Fujiwara Y. Breast Cancer Res Treat; 2007 Jul; 103(3):313-8. PubMed ID: 17063267 [Abstract] [Full Text] [Related]
12. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Pickles MD, Lowry M, Manton DJ, Gibbs P, Turnbull LW. Breast Cancer Res Treat; 2005 May; 91(1):1-10. PubMed ID: 15868426 [Abstract] [Full Text] [Related]
17. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy. Keam B, Im SA, Kim HJ, Oh DY, Kim JH, Lee SH, Chie EK, Han W, Kim DW, Cho N, Moon WK, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ. Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948 [Abstract] [Full Text] [Related]